Cite
HARVARD Citation
Siebert, N. et al. (2016). Pharmacokinetics and pharmacodynamics of ch14.18/CHO in relapsed/refractory high-risk neuroblastoma patients treated by long-term infusion in combination with IL-2. MAbs. 8 (3), pp. 604-616. [Online].